//
Frederick Varn
Taylor Wade
Tathiane Malta
Thais Sabedot
Floris Barthel
Hoon Kim
Nazia Ahmed
Indrani Datta
Jill Barnholtz-Sloan
Spyridon Bakas
Fulvio D'Angelo
Hui Gan
Luciano Garofano
Jason Huse
Mustafa Khasraw
Emre Kocakavuk
Simona Migliozzi
David Ormond
Sun Ha Paek
Erwin Van Meir
Annemiek Walenkamp
Colin Watts
Michael Weller
Tobias Weiss
Pieter Wesseling
Lucy Stead
Laila Poisson
Houtan Noushmehr
Antonio Iavarone
Roel Verhaak
VU University Medical Center, Amsterdam, Netherlands
The Jackson Laboratory for Genomic Medicine, Farmington, CT
Seoul National University College of Medicine, Seoul, Republic of Korea
University of Alabama at Birmingham, Birmingham, Alabama, USA
University of Leeds, Leeds, UK
Henry Ford Cancer Institute, Detroit, MI, USA
University of Pennsylvania, Philadelphia, PA, USA
Duke University Medical Center, Durham, NC, USA
Columbia University Medical Center, New York, NY, USA
University of Colorado, Aurora, USA
MD Anderson Cancer Center, Houston, Texas, USA
Hermelin Brain Tumor Center, Henry Ford Health System, Detroit, MI, USA
University Hospital and University of Zurich, Zurich, Switzerland
UNIVERSITY OF SO PAULO, São Paulo, Brazil
Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK
Henry Ford Health System, Detroit, MI, USA
Olivia Newton-John Cancer Research Institute, Heidelberg, Melbourne, VIC, Australia
Case Western Reserve University School of Medicine and University Hospitals of Cleveland, Cleveland, OH, USA
University Medical Center Groningen, Groningen, THE NETHERLANDS
Jackson Laboratory, Farmington, USA
Laboratory of Molecular Neuro-Oncology, Department of Neurology, University Hospital Zurich and University of Zurich, Zurich, Switzerland
Netherlands
Australia
United States
Switzerland
Republic of South Korea
Brazil
United Kingdom
N/A
Oncology (ONC)
Gliomas
Cyclin Dependent Kinase Inhibitor 2A
N/A
N/A
N/A
NA
N/A
N/A
Final